Building innovative, effective RWE platforms

EMR as a highly powerful European RWD source

Multi-country drug utilization studies in Europe

Improving drug benefit-risk assessment

Scandinavian Real-World Data Conference Nov. 20th, Copenhagen

IMS Health Enriched Real-World Data Study

HEOR, Pharmacoepidemiology & Drug Safety

IMS Health Workshop World Orphan Drug Congress

E360 (TM) Real-World Evidence Solutions

How patient subpopulations are changing the commercialization of oncology products

Advocacy and the cancer patient viewpoint

IMS Health Real-World Evidence Solutions at ISPOR November 2015

IMS Health RWES: The Future of Real-World Insights in Cancer

The challenges of codes in RWD

Convergence of HTA assessments in Europe

Prospective identification of drug safety signals

IMS Health Real-World Evidence Brochure

How predictive analytics can help find the rare disease patient

The Current Oncology Pipeline: Development & Launch

Malignant melanoma: A transformation in treatment